BM
Boston Medical Sciences
Japan · Healthtech · AI
Boston Medical Sciences develops AI-assisted colorectal cancer screening technology.
Product
Boston Medical Sciences is a Tokyo medical technology company developing AI-assisted colorectal cancer screening. Its system combines virtual bowel cleansing with polyp detection in CT images, aiming to reduce the preparation burden associated with conventional examinations.
Founded in 2023, the company is preparing its technology for clinical use in Japan and working toward US expansion. It has completed a domestic clinical trial; its product remains under development.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series B | ¥5.6B | Beyond Next Ventures, Inc. — LeadNomura SPARX Investment (Japan Growth Capital Investment Corporation) — LeadFukoku CVC Fund THE MUTUAL for Next 100 — Role not disclosedGlobal Brain Flagship Fund IX — Role not disclosedMeiji Yasuda Future Co-Creation Fund — Role not disclosedTAKANAWA GATEWAY Global Co-Benefits Fund L.P. — Role not disclosedTOHO Ventures — Role not disclosed |
Investors
Beyond Next Ventures, Inc.Led Series BNomura SPARX Investment (Japan Growth Capital Investment Corporation)Led Series BFukoku CVC Fund THE MUTUAL for Next 100Series BGlobal Brain Flagship Fund IXSeries BMeiji Yasuda Future Co-Creation FundSeries BTAKANAWA GATEWAY Global Co-Benefits Fund L.P.Series BTOHO VenturesSeries BCoverage
Nov 13, 2026Boston Medical Sciences · Series BSimilar companies
QQUIKTECHQUIKTECH combines AI experiment design and laboratory automation for scientific and industrial research.CN¥100M · Series A
ZCZ Creative PartnersZ Creative Partners helps businesses measure and improve how AI systems understand and recommend their brands.¥50M · Seed
Agile RobotsAgile Robots develops AI-powered industrial robots, robotic arms, hands and automation software.$500M · Series F